A detailed history of Atria Wealth Solutions, Inc. transactions in Sanofi stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 21,947 shares of SNY stock, worth $1.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,947
Previous 20,691 6.07%
Holding current value
$1.05 Million
Previous $1 Million 26.12%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$48.54 - $58.53 $60,966 - $73,513
1,256 Added 6.07%
21,947 $1.27 Million
Q2 2024

Jul 22, 2024

BUY
$45.39 - $50.36 $47,160 - $52,324
1,039 Added 5.29%
20,691 $1 Million
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $150,151 - $172,239
3,282 Added 20.05%
19,652 $955,000
Q4 2023

Feb 02, 2024

BUY
$43.13 - $54.79 $51,971 - $66,021
1,205 Added 7.95%
16,370 $814,000
Q3 2023

Nov 08, 2023

BUY
$50.95 - $55.2 $348,854 - $377,954
6,847 Added 82.32%
15,165 $813,000
Q2 2023

Aug 03, 2023

BUY
$50.45 - $57.18 $150,845 - $170,968
2,990 Added 56.12%
8,318 $448,000
Q1 2023

Aug 22, 2023

BUY
$45.86 - $54.45 $100,937 - $119,844
2,201 Added 26.46%
10,519 $572,000
Q1 2023

Jun 14, 2023

SELL
$45.86 - $54.45 $238,059 - $282,649
-5,191 Reduced 49.35%
5,328 $289,000
Q1 2023

May 10, 2023

BUY
$45.86 - $54.45 $184,448 - $218,997
4,022 Added 61.91%
10,519 $572,000
Q4 2022

Aug 30, 2023

SELL
$38.86 - $48.55 $116,191 - $145,164
-2,990 Reduced 35.95%
5,328 $258,000
Q4 2022

Feb 13, 2023

BUY
$38.86 - $48.55 $41,424 - $51,754
1,066 Added 19.63%
6,497 $314,000
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $18,312 - $49,446
492 Added 9.96%
5,431 $277,000
Q2 2022

Aug 15, 2022

BUY
$48.99 - $57.46 $241,961 - $283,794
4,939 New
4,939 $247,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Atria Wealth Solutions, Inc. Portfolio

Follow Atria Wealth Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.